-
Copper market production capacity has not yet been put into the spot is still tight
Time of Update: 2022-12-14
Trend analysis: On the 12th, the spot market premium became weaker than the previous trading day, and the high premium brand gave up a large range, making the price difference between various brands r
-
Dow's sales decreased year-over-year
Time of Update: 2022-11-25
Sales decreased 10% sequentially from the prior quarter, with declines in all operating segments and regions.
Sales decreased 10% sequentially from the prior quarter, with declines in all operating segments and regions.
Sales decreased 10% sequentially from the prior quarter, with declines in all operating segments and regions.
-
Chemical sales Central China's auction sales help Sino-Korea Petrochemical styrene volume and price increase
Time of Update: 2022-10-31
In that month, Sinopec and South Korea completed the auction of 1,792 tons of styrene, with a total price increase of 137,000 yuan, helping the company to increase both volume and price In May, Sinopec Huazhong accurately researched and judged the market trend.
-
Yangzi Petrochemical's new EVA products were exported for the first time
Time of Update: 2022-09-20
, Ltd. actively coordinated products to leave the factory in bulk packages, and adjusted the delivery plan according to the shipping schedule to ensure the smooth flow of products In addition, Yangzi Petrochemical EVA has been shipped in the form of shared pallets, but the pallets are difficult to recycle overseas.
-
Should not be missed
Time of Update: 2022-01-09
The FDA has approved brivaracetam (Briviact; UCB Pharma) CV tablets and oral solution for extended indications, which is a drug for the treatment of children with partial seizures .
Efgartigimod is a pioneering targeted therapy drug, and its approval provides a new treatment option for patients with rare diseases .
-
J Am Acad Dermatol: Study on the efficacy and safety of cathepsin S inhibitors in patients with moderate and severe psoriasis
Time of Update: 2022-01-08
Approximately 20% of patients with psoriasis are moderate to severe and require systemic treatment with cytokine-targeted biological agents .
The primary endpoint was the proportion of patients who achieved a Psoriasis Area and Severity Index (PASI) -75 response after 12 weeks of treatment .
-
2 billion large varieties of parecoxib sodium for injection
Time of Update: 2022-01-02
On November 29, Buchang Pharmaceuticals announced that its wholly-owned subsidiary Shandong Danhong's parecoxib sodium for injection was approved for listing .
Parecoxib sodium for injection is a selective COX-2 inhibitor, and its terminal sales in China's public medical institutions will exceed 2 billion yuan in 2020 .
-
Vietnam pangasius exports rebounded rapidly, and China's sales in November increased by 120% month-on-month
Time of Update: 2021-12-24
Tam Nguyen, CEO of Vietnam Pangasius Group, told UCN that the company achieved excellent sales results in November.
China Tam Nguyen, CEO of Vietnam Pangasius Group, told UCN that the company achieved excellent sales results in November.
-
Zhengda Tianqing, Osaikang... grab 1.5 billion injections
Time of Update: 2021-11-05
A few days ago, the official website of the State Food and Drug Administration showed that Liaoning Haisco Pharmaceutical's Palonosetron Hydrochloride Injection was approved as a supplementary application.
According to data from Meinenet, the sales of Palonosetron Hydrochloride Injection in China's public medical institutions in 2020 will exceed 1.
-
Spin-off business accelerates transformation
Time of Update: 2021-08-05
3 billion US dollars in sales in the second year of its launch, making it the king of HIV drugs .
Despite the impact of Biktarvy, GSK’s HIV drug sales growth rate has declined, but the Triumeq and Tivicay developed by it were still handed over last year.
-
Day 3 of the health care negotiations: PD-1/L1 price war! Domestic quotations for domestic enterprises are less than 40,000/year
Time of Update: 2020-12-23
According to Sina Pharmaceuticals, this morning or mainly for the import of PD-1 negotiations, such as Merca East, AstraZeneta have entered the market, the afternoon is mainly for domestic PD-1 product negotiations, involving Hengrui Pharmaceuticals, Baiji Shenzhou, Junshi Biological and so on.
-
Zhangzhou Municipal Market Supervision Bureau completed the set-up of uniodized salt supply outlets
Time of Update: 2020-11-28
In order to further strengthen the city's salt franchise management, regulate the supply of uniodized salt, to ensure the quality and safety of uniodized salt, recently, Zhangzhou City Market Supervi
-
Huiyu Pharmaceutical's paclitaxel injection plans to be included in priority review
Time of Update: 2019-12-26
On December 25, CDE official website showed that Huiyu pharmaceutical's Paclitaxel injection was proposed to be included in the priority review for the reason that "the same production line has been l
-
Transformation of pharmaceutical enterprises: game between profit and service
Time of Update: 2015-05-29
Source: Biovalley 2015-5-29 "we should always bear in mind that drugs are designed to save people and not seek profits, but profits will follow If we remember this, we will never be unprofitable; the
